Medicine Description asthmobronchin 20mg
Asthmobronchin 20mg Tablets is a medication that contains the active ingredient theophylline, which belongs to a class of drugs known as methylxanthines. Theophylline works by relaxing the smooth muscles of the airways and blood vessels, leading to dilation or widening of these structures. This action is primarily mediated through the inhibition of phosphodiesterase enzymes, which breaks down cyclic adenosine monophosphate (cAMP). By increasing cAMP levels, theophylline promotes bronchodilation, enhances respiratory function, and improves airflow in patients with obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Additionally, theophylline may exhibit anti-inflammatory effects and enhance mucociliary clearance, contributing to its therapeutic efficacy in managing symptoms associated with bronchospasm and airway obstruction.
Indications and Uses of Asthmobronchin 20mg Tablets
- Management of bronchial asthma
- Relief of symptoms in chronic obstructive pulmonary disease (COPD)
- Prevention of bronchospasm
- Treatment of acute respiratory distress in certain patients
Side Effects of Asthmobronchin 20mg Tablets
- Nausea and vomiting
- Headache
- Insomnia
- Increased heart rate (tachycardia)
- Gastrointestinal disturbances
- Restlessness
- Palpitations
Storage and Handling
Store Asthmobronchin 20mg Tablets in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiration date indicated on the package.
Patient Advice and Precautions
Patients should be advised to take Asthmobronchin 20mg Tablets as prescribed and not to exceed recommended use. Regular monitoring of therapeutic levels may be necessary to prevent toxicity. It is important to report any unusual symptoms, especially cardiac or gastrointestinal issues, to a healthcare provider. Additionally, patients should be educated on recognizing signs of worsening respiratory distress and the importance of adhering to their asthma action plan.